Larry has a deep understanding of what drives government enforcement actions, and how to defend against them, in the health care and life sciences industries. As a trial lawyer and then official in the Civil Fraud Section of the U.S. Department of Justice, he litigated and supervised hundreds of False Claims Act and qui tam cases nationally. In his litigation practice, Larry has successfully represented hospitals and health care systems, laboratories, pharmaceutical and device manufacturers, and health care executives against fraud and abuse allegations and investigations brought by federal and state agencies. He is consistently recognized among the nation’s leading health care defense attorneys.
Larry’s health care and life sciences litigation practice focuses on defending clients against allegations and investigations of fraud and abuse involving governmental programs. He is highly experienced in representing clients against actions brought by federal and state agencies including the US Department of Justice (DOJ), the Department of Health and Human Services Office of the Inspector General (HHS OIG), the United States Attorneys’ Offices, and state OIGs and Medicaid Fraud Control Units (MFCUs).
Larry’s practice is based on his 24-years of experience handling complex civil litigation, often in the context of parallel proceedings, and achieving global resolutions. In addition to enforcement defense, Larry counsels clients through internal investigations, corporate compliance, investor due diligence reviews, and health care bankruptcies involving governmental liabilities. His clients include hospitals and health systems, dialysis providers, clinical laboratories, medical equipment companies, pharmaceutical and device manufacturers, and health care executives.
Prior to private practice, Larry served as an Assistant Director with the Civil Fraud Section of the DOJ and focused solely on the False Claims Act and its qui tam provisions. At DOJ he supervised hundreds of qui tam cases filed in US district courts throughout the country, was part of the leadership team for the pharmaceutical enforcement initiative, and managed high-profile actions often involving multiple US Attorneys’ Offices and federal agencies.
Prior to his position as Assistant Director, Larry served with the Civil Fraud Section as a trial attorney focused on health care fraud and defense procurement. He co-led the notable investigation and prosecution of national independent clinical laboratories known as “Operation LABSCAM.” For his achievements, Larry was highly-recognized by the Attorney General with the Department’s highest and second highest awards, as well as multiple awards from the HHS OIG and the MFCUs.
Following law school, Larry served as a law clerk for the Honorable Richard Cardamone of the U.S. Court of Appeals for the Second Circuit.
More Legal and Business Bylines From Laurence J. Freedman
- EnforceMintz — False Claims Act Statistical Year In Review - (Posted On Wednesday, March 20, 2024)
- EnforceMintz — Some of 2023’s Largest FCA Resolutions Involved Stark Law Allegations - (Posted On Monday, February 12, 2024)
- EnforceMintz — DOJ’s Limited Use of NPAs and DPAs in Criminal Health Care Investigations - (Posted On Monday, February 12, 2024)
- EnforceMintz — COVID-19 Fraud Enforcement Unlikely to Slow Down in 2024 - (Posted On Thursday, February 08, 2024)
- The Supreme Court’s SuperValu Decision on the “Knowingly” Element in the False Claims Act: Protecting Against Liability When There is Regulatory Ambiguity - (Posted On Wednesday, June 14, 2023)
- CMS Proposed Rule for Refunding Overpayments Would Align With False Claims Act “Knowledge” Standard - (Posted On Tuesday, January 17, 2023)
- Serial Relator Brings Multiple Lawsuits Alleging False Claims Act Violations Premised on Paycheck Protection Program Fraud - (Posted On Wednesday, November 02, 2022)
- Supreme Court Declines to Weigh in on False Claims Act Pleading Requirements - (Posted On Tuesday, October 25, 2022)
- False Claims Act Settlements and Judgments Exceed $5.6 Billion in Fiscal Year 2021 - (Posted On Wednesday, February 02, 2022)
- Senator Grassley and Others Propose Amendments to the False Claims Act - (Posted On Monday, August 02, 2021)